Loading clinical trials...
Loading clinical trials...
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Conditions
Locations
666
United States
University South Alabama Medical Center
Mobile, Alabama, United States
Black Warrior Research
Northport, Alabama, United States
Scottsboro Quick Care Clinic
Scottsboro, Alabama, United States
Alaska Heart Institute
Anchorage, Alaska, United States
Phoenix Heart PLLC
Glendale, Arizona, United States
Mercy Cinic Hot Springs Communities
Hot Springs, Arizona, United States
Start Date
November 7, 2011
Primary Completion Date
January 10, 2020
Completion Date
January 10, 2020
Last Updated
March 29, 2021
NCT05093673
NCT07371455
NCT06258538
NCT06870812
NCT07253181
NCT05147792
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions